1. Eosinophil activation and in situ interleukin-5 production by mononuclear cells in skin lesions of patients with drug hypersensitivity.
- Author
-
Mikami C, Ochiai K, Umemiya K, Matsumura R, Kagami M, Tomioka H, Sato Y, and Tanabe E
- Subjects
- Adult, Aged, Biopsy, Needle, CD4-CD8 Ratio, Drug Eruptions etiology, Drug Eruptions physiopathology, Female, Humans, Immunohistochemistry, In Situ Hybridization, Leukocytes, Mononuclear pathology, Lymphocyte Activation, Male, Middle Aged, T-Lymphocytes pathology, Drug Eruptions pathology, Eosinophilia chemically induced, Eosinophilia pathology, Interleukin-5 analysis
- Abstract
In order to determine the inflammatory mechanisms of skin lesions in patients with drug hypersentivity, we examined eosinophil activation and interleukin-5 (IL-5) production in infiltrating lymphocytes. First, we showed that the number of peripheral eosinophils and the level of serum IL-5 at the eruption-active stage were both significantly higher than those in healed skin eruptions. Histological and immunohistological examination revealed that CD4+ T cells and eosinophils significantly more densely infiltrated drug eruptions than control skin lesions. The infiltrating eosinophils were also shown to be activated by immunostaining using anti-secreted formed eosinophilic cationic protein monoclonal antibody. The expression of mRNA for IL-5 in the infiltrating mononuclear cells at drug eruptions was shown by in situ hybridization. These results suggest that infiltrating CD4+ T cells might regulate both peripheral and tissue eosinophils and facilitate allergic inflammation at drug eruptions by means of IL-5 production.
- Published
- 1999
- Full Text
- View/download PDF